Search Results

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

• Authors : Aoki D; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.; Akasaka Sanno Medical Center, International University of Health and Welfare Graduate School, Tokyo, Japan.

Subjects: Indazoles*/Indazoles*/Indazoles*/adverse effects ; Indazoles*/Indazoles*/Indazoles*/therapeutic use ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

• Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Sep; Vol. 35 (5), pp. e114.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print Cited Medium:

Record details

Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy.

• Authors : Ito, Mamoru¹ (AUTHOR) ; Kubo, Makoto^2,3 (AUTHOR) ; Kawaji, Hitomi³ (AUTHOR)

• Source: Cancers. Dec2023, Vol. 15 Issue 23, p5608. 16p.

Record details

First Isolation and Identification of Homologous Recombination Events of Porcine Adenovirus from Wild Boar.

• Authors : Oba, Mami^1,2 (AUTHOR); Borjigin, Sumiya¹ (AUTHOR); Kikuchi, Fuka^1,3 (AUTHOR)

Subjects: *WILD boar; *HUMAN adenoviruses; *ADENOVIRUSESJAPAN

• Source: Viruses (1999-4915). Nov2022, Vol. 14 Issue 11, p2400. 11p.

Record details

Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).

• Authors : Hiroshi Asano¹; Katsutoshi Oda²; Kosuke Yoshihara³

• Source: Journal of Gynecologic Oncology. Jul2022, Vol. 33 Issue 4, p1-12. 12p.

Record details

Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients.

• Authors : Sugino K; Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8510, Japan.; Tamura R

Subjects: Germ-Line Mutation* ; Homologous Recombination*; Adenocarcinoma, Clear Cell/Adenocarcinoma, Clear Cell/Adenocarcinoma, Clear Cell/*genetics

• Source: Scientific reports [Sci Rep] 2019 Nov 28; Vol. 9 (1), pp. 17808. Date of Electronic Publication: 2019 Nov 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.

• Authors : Ueno T; Breast Surgical Oncology, The Cancer Institute Hospital of JFCR, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. .; Division of Cancer Genomic Medicine Development, Advanced Medical Development Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan. .

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology

• Source: BMC medicine [BMC Med] 2022 Apr 25; Vol. 20 (1), pp. 136. Date of Electronic Publication: 2022 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

• Authors : Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.; Kondo E

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use; Female

• Source: Journal of gynecologic oncology [J Gynecol Oncol] 2021 Mar; Vol. 32 (2), pp. e16. Date of Electronic Publication: 2020 Dec 10.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer.

• Authors : Uekusa, Ryosuke¹ (AUTHOR); Yokoi, Akira^1,2 (AUTHOR) ‐u.ac.jp; Watanabe, Eri³ (AUTHOR)

• Source: Cancer Medicine. Apr2024, Vol. 13 Issue 7, p1-10. 10p.

Record details

Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer.

• Authors : Uekusa, Ryosuke; Yokoi, Akira; Watanabe, Eri

Subjects: JAPANESE people; OVARIAN cancer; CANCER patientsJAPAN

• Source: Scientific Reports; 6/1/2024, Vol. 14 Issue 1, p1-9, 9p

Record details

Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses.

• Authors : Terada Y; Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.; Matsui N

Subjects: Cat Diseases/Cat Diseases/Cat Diseases/*virology ; Coronavirus Infections/Coronavirus Infections/Coronavirus Infections/*veterinary ; Coronavirus, Canine/Coronavirus, Canine/Coronavirus, Canine/*genetics

• Source: PloS one [PLoS One] 2014 Sep 02; Vol. 9 (9), pp. e106534. Date of Electronic Publication: 2014 Sep 02 (Print Publication: 2014).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details